ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1290

$1.54M Total Retail Price of All Prescriptions

Rank: 19 out of 1290

1,199 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,199 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

1% of this provider’s 1,199 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 2,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
TRAZODONE HCL 946 135 1 44
ALPRAZOLAM 752 70 2 47
QUETIAPINE FUMARATE 634 91 3 80
ZOLPIDEM TARTRATE 622 79 4 15
RISPERIDONE 605 136 5 68
DIVALPROEX SODIUM 580 112 6 121
BENZTROPINE MESYLATE 575 40 R 7 108
CITALOPRAM HBR 568 97 8 29
CYMBALTA 452 43 9 59
ABILIFY 418 22 10 114
LAMOTRIGINE 416 46 11 100
SERTRALINE HCL 368 97 12 36
PAROXETINE HCL 354 70 13 84
ZIPRASIDONE HCL 331 26 14 253
ESCITALOPRAM OXALATE 309 41 15 63
FLUOXETINE HCL 292 15 16 79
MIRTAZAPINE 290 48 17 93
BUPROPION HCL SR 257 19 18 187
SEROQUEL 236 52 19 186
LITHIUM CARBONATE 224 34 20 223
SEROQUEL XR 212 26 21 151
VENLAFAXINE HCL ER 206 29 22 154
OLANZAPINE 201 20 23 169
PRISTIQ ER 175 32 24 414
VENLAFAXINE HCL 167 41 25 327
BUPROPION XL 162 11 26 143
AMPHETAMINE SALT COMBO 140 0 S2 27 317
DIVALPROEX SODIUM ER 130 0 28 197
TEMAZEPAM 124 24 29 71
LEXAPRO 123 43 30 173
RISPERDAL CONSTA 123 24 30 372
LORAZEPAM 122 22 32 132
GEODON 114 0 33 442
FLUPHENAZINE HCL 113 0 34 294
GABAPENTIN 110 13 35 8
BUSPIRONE HCL 110 0 35 178
HALOPERIDOL 102 0 37 204
AMITRIPTYLINE HCL 94 28 R 38 97
CARBAMAZEPINE 91 0 39 191
DOXEPIN HCL 89 0 40 325
TOPIRAMATE 86 0 41 91
HYDROXYZINE PAMOATE 77 0 R 42 222
SAPHRIS 75 0 43 551
CLONAZEPAM 67 0 44 170
DIAZEPAM 64 13 45 261
DONEPEZIL HCL 63 55 46 13
LUNESTA 60 12 47 370
VIIBRYD 59 0 48 600
FLUVOXAMINE MALEATE 57 13 49 452
LISINOPRIL 54 29 50 5
LOXAPINE 52 13 51 638
SIMVASTATIN 50 38 52 1
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.